These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 9876475
21. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM. Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166 [Abstract] [Full Text] [Related]
22. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Hartman A, te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Kemper HC, Hop WC, van den Heuvel-Eibrink MM, Pieters R. Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791 [Abstract] [Full Text] [Related]
23. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease? Muszynska-Roslan K, Konstantynowicz J, Panasiuk A, Krawczuk-Rybak M. Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007 [Abstract] [Full Text] [Related]
24. Vitamin K status is associated with childhood bone mineral content. van Summeren MJ, van Coeverden SC, Schurgers LJ, Braam LA, Noirt F, Uiterwaal CS, Kuis W, Vermeer C. Br J Nutr; 2008 Oct; 100(4):852-8. PubMed ID: 18279558 [Abstract] [Full Text] [Related]
25. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. Kadan-Lottick N, Marshall JA, Barón AE, Krebs NF, Hambidge KM, Albano E. J Pediatr; 2001 Jun; 138(6):898-904. PubMed ID: 11391336 [Abstract] [Full Text] [Related]
26. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A. Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073 [Abstract] [Full Text] [Related]
27. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease. Athale UH, Siciliano SA, Crowther M, Barr RD, Chan AK. Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008 [Abstract] [Full Text] [Related]
28. Vitamin D status and bone biomarkers in childhood cancer. Atkinson SA. Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):479-82; discussion 486. PubMed ID: 18064644 [Abstract] [Full Text] [Related]
31. Bone mineral metabolism and its relationship to leptin levels in survivors of childhood leukemia and lymphoma. Yaris N, Sözen E, Erduran E, Okten A, Orem A, Cakirbay H. Pediatr Hematol Oncol; 2005 Sep; 22(6):489-98. PubMed ID: 16169815 [Abstract] [Full Text] [Related]
32. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D]. Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M. Przegl Lek; 2007 Sep; 64(9):552-8. PubMed ID: 18510075 [Abstract] [Full Text] [Related]
33. Acute lymphoid leukemia. No evidence of consistent chemotherapy-induced intestinal malabsorption. Halton J, Atkinson SA, Bradley C, Dawson S, Barr RD. Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):271-6. PubMed ID: 8328639 [Abstract] [Full Text] [Related]
34. Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience. Lethaby C, Wiernikowski J, Sala A, Naronha M, Webber C, Barr RD. J Pediatr Hematol Oncol; 2007 Sep; 29(9):613-6. PubMed ID: 17805035 [Abstract] [Full Text] [Related]
35. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency. Lausen B, Schmiegelow K, Andreassen B, Madsen HO, Garred P. Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622 [Abstract] [Full Text] [Related]
36. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH. Pediatr Blood Cancer; 2012 Jul 15; 59(1):77-82. PubMed ID: 22190454 [Abstract] [Full Text] [Related]
37. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology. Haematologica; 2002 Feb 15; 87(2):154-66. PubMed ID: 11836166 [Abstract] [Full Text] [Related]
38. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency. Gonc EN, Kandemir N. Clin Endocrinol (Oxf); 2007 May 15; 66(5):672-7. PubMed ID: 17381489 [Abstract] [Full Text] [Related]
39. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C. Transpl Int; 2002 Mar 15; 15(2-3):73-80. PubMed ID: 11935163 [Abstract] [Full Text] [Related]
40. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium. Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD. Arthritis Rheum; 2008 Oct 15; 58(10):3255-63. PubMed ID: 18821668 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]